Clinical Trial Update: The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paricalcitol capsules for reducing albuminuria in patients with type 2 diabetic nephropathy on renin-angiotensin system inhibitors has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Nephropathy

Drugs mentioned

• Zemplar (Paricalcitol)

Snippet

Sponsor: Abbott | Conditions: Diabetic Nephropathy, Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2010-09-14